The Next Edition
  • Home
  • About Us
  • News
  • Featured
  • Investigations
  • Foreign
  • Special Reports
  • Entertainment
  • Interviews
  • Advert Rate
No Result
View All Result
The Next Edition
No Result
View All Result
  • Home
  • About Us
  • News
  • Featured
  • Investigations
  • Foreign
  • Special Reports
  • Entertainment
  • Interviews
  • Advert Rate
Home Top News

WHO Announces 3 New Drugs For COVID-19 Clinical Trials

Next Edition by Next Edition
August 11, 2021
in Top News
WHO Warns Against Use Of Masks During Exercise
0
SHARES
0
VIEWS
Share on FacebookShare on TwitterShare on Whatsapp

Three new candidate drugs are being tested in the latest phase of global Solidarity clinical trials to find effective treatments against COVID-19, the World Health Organisation (WHO) announced on Wednesday.

The therapies — artesunate, imatinib and infliximab — will be tested on hospitalised COVID-19 patients in 52 countries under the Solidarity PLUS programme.

You might also like

Lagos Re-opens Oko-Oba Abbatoir

Gunmen Abduct, Kill Anambra Chief After N15m Ransom

One Killed, Five Injured As Landmine Explodes In Imo Market

There have been more than 203 million cases of the disease recorded globally as of Wednesday, according to WHO.

The world hit the 200 million mark last week, just six months after cases passed 100 million.

Speaking during a press conference in Geneva, WHO’s Director-General, Dr. Tedros Ghebreyesus underscored the critical need to find more effective and accessible COVID-19 therapeutics.

“We already have many tools to prevent, test for and treat COVID-19, including oxygen, dexamethasone and IL-6 blockers.

“But we need more, for patients at all ends of the clinical spectrum, from mild to severe disease. And we need health workers that are trained to use them in a safe environment,” he said.

The three drugs were selected by an independent panel for their potential in reducing the risk of death in people hospitalised for COVID-19.

They are already being used to treat other conditions.

Artesunate is a medicine for severe malaria, imatinib is used for certain cancers, including leukemia, while infliximab is used to treat Crohn’s Disease, rheumatoid arthritis and other diseases of the immune system.

Manufacturers Ipca, Novartis and Johnson & Johnson, donated the drugs for the trial.

Solidarity PLUS is the largest global collaboration among WHO’s 194 Member States, with thousands of researchers in over 600 hospitals participating.

READ ALSO: FG Approves Over N4bn For Fuelling Police Vehicles

Finland is among the 52 countries taking part, 16 more than the initial Solidarity Trial, and contributes to the COVAX vaccine solidarity initiative.  Two university hospitals in Finland have been the first worldwide to begin the second phase.

Hanna Sarkkinen, the country’s Minister of Social Affairs and Health, said clinical trials had a great potential to save lives.

“Even though there are approximately 3,000 clinical studies on COVID-19, most of them are too small to yield significant information. We need clinical trials that are large enough to bring better treatments for COVID-19 patients,” she said.

Four drugs were evaluated under the initial Solidarity Trial in 2020, which showed that remdesivir, hydroxychloroquine, lopinavir and interferon had little or no effect on hospitalised patients with COVID-19. (NAN)

Tags: Covid-19FACEMASKHealth ministerNCDCvaccinationVACCINES
Next Edition

Next Edition

Recommended For You

Lagos Shuts Oko-Oba Abattoir Over Unsanitary Practices

Lagos Re-opens Oko-Oba Abbatoir

  The Lagos State Government has directed the immediate re-opening of the Oko-Oba Abbatoir in Agege following the fulfillment of sanitation and hygienic prescriptions by the operators. The...

Gunmen Invade Monarch’s Palace In Benue, Kill Son, Abduct Daughter

Gunmen Abduct, Kill Anambra Chief After N15m Ransom

  Panic has gripped the Nimo community in the Njikoka Local Government Area of Anambra State following the murder of a prominent traditional titleholder and community leader popularly...

Police Arrest Woman Taking Daughters To Bandits For Sex

One Killed, Five Injured As Landmine Explodes In Imo Market

A landmine exploded inside Eke Ubaheze Market Square in Awo-Idemili, Orsu LGA of Imo state on Tuesday, killing one person and injuring five others. The blast, which occurred...

Imo NDLEA Confirms Arrest Of Alleged Notorious Drug Dealer

NDLEA Seizes 1.94m KG Of Illicit Drugs In Abia, Arrests 222 Suspects

  The National Drug Law Enforcement Agency (NDLEA), Abia State Command, said it has seized about 1.94 million illicit drugs, and arrested 222 suspects in one year.  ...

Next Post
COVID-19: Oxygen Demand May Hit 750 Cylinders Daily – Lagos Govt

LASG Arrests 30 Persons For Rebuilding Demolished Illegal Structures




Related News

British PM Theresa May under pressure to resign

British PM May under pressure to resign

COVID-19: Gov. Masari Orders Closure Of Land Borders With 4 States, Niger Republic

COVID-19: Gov. Masari Orders Closure Of Land Borders With 4 States, Niger Republic

Nigerian Idol Winner, Kingdom, Gets Bayelsa Govt. Scholarship

Nigerian Idol Winner, Kingdom, Gets Bayelsa Govt. Scholarship




The Next Edition

Office Address

3B, Agboola Aina street, Off Toyin Street,
Ikeja, Lagos.

Quick Contact Details

Phone:
08033018430
Whatsapp:
08051679910

Email:
[email protected]
[email protected]

Categories

  • Aviation
  • Beauty
  • Breaking News
  • Business
  • Columnists
  • Editorial
  • Entertainment
  • Fashion
  • Featured
  • Football
  • Foreign
  • Headline News
  • Home & Garden
  • Interviews
  • Investigations
  • North Central
  • North East
  • North West
  • Opinion
  • Parenting
  • Politics
  • Relationships
  • South East
  • South West
  • South-South
  • Special Reports
  • Sports
  • Top News
  • Vox Pops

© Next Edition Business Development Limited

  • About Us
  • Advert Rate
  • Contact Us
  • Privacy Policy
  • Terms of Use
No Result
View All Result
  • Home
  • About Us
  • News
  • Featured
  • Investigations
  • Foreign
  • Special Reports
  • Entertainment
  • Interviews
  • Advert Rate

© Next Edition Business Development Limited